0.20
-0.0919(-31.78%)
Currency In USD
Address
13576 Walnut Street
Omaha, NE 68144
United States of America
Phone
833 931 6330
Website
Sector
Healthcare
Industry
Biotechnology
Employees
3
First IPO Date
N/A
| Name | Title | Pay | Year Born |
| Dr. Joseph Sinkule Pharm.D. | Founder, Chief Executive Officer, Chairman of the Board & Secretary | 480,000 | 1954 |
| Mr. Jeffrey LeBlanc | Chief Financial Officer | 401,506 | 1973 |
| Dr. Bradford A. Navia M.D., Ph.D. | Chief Medical Advisor | 0 | 1955 |
| Dr. Miguel Chillon Rodriguez | Chief Scientific Advisor & Consultant | 0 | 1966 |
Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.